A way of predicting which patients will respond well to treatment with a common chemotherapy drug used in breast cancer was unveiled at the European Cancer Conference (ECCO 14) today (Monday 24 September).
A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.
Huge challenges face healthcare professionals and policy makers in planning for, and providing cancer care over the next decade or so. Chief amongst these will be ensuring that healthcare professionals have the skills and knowledge to treat a greater number of elderly people with cancer, that current inappropriate ageist attitudes towards the elderly cease, and that advances are made in ensuring that cancer patients are able to comply with their treatment.
Recent political decisions have had serious consequences for European oncology, said Professor John Smyth at ECCO 14, the European Cancer Conference, today.
Implementation of the Physical Agents (Electromagnetic Fields) Directive 2004/40/EC in all Member States could effectively halt the use of magnetic resonance imaging (MRI), an important tool in cancer diagnosis, treatment, and research, a scientist told a press conference at the European Cancer Conference (ECCO 14) today (Monday September 24). The Directive is due to be implemented across Europe by April 2008.
A novel strategy to hopefully beat into oblivion one of the most aggressive forms of acute myelogenous leukemia combines the strengths of some of the newest leukemia agents, researchers say.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University medical expert.
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world’s first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
On World Alzheimer’s Day, the Alzheimer Society of Canada is pleased to announce its receipt of a $1 million legacy gift.
Roche announced that the European Medicines Agency’s (EMEA) Committee for Human Medicinal Products (CHMP) has recommended that Viracept’s marketing authorization is re-instated in Europe following its suspension earlier this summer.